People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LipimetiX Development, Inc. | — | Pharmaceuticals | Seed | $1.0M | $38.5M | 2016 |
PHILLIP M FRIDEN, PH.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PHILLIP M FRIDEN, PH.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ERIC M MORREL, PH.D. | 1 | 1 |
| JOHN M HOLLIMAN, III | 1 | 1 |
| DENNIS I GOLDBERG, PH.D. | 1 | 1 |
| RANDOLPH C STEER, M.D., PH.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.